Stay updated on VELIA Clinical Trial: Veliparib in Ovarian Cancer
Sign up to get notified when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.

Latest updates to the VELIA Clinical Trial: Veliparib in Ovarian Cancer page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.3.4 is now shown, replacing the previous Revision: v3.3.3.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe page's Locations section has been expanded to include a large number of sites across multiple regions, broadening geographic coverage for the study.SummaryDifference2%

- Check59 days agoChange DetectedPublications section text updated: it now states that publications are automatically filled from PubMed and includes Revision: v3.3.2, while the previous PubMed description and Revision: v3.2.0 are removed.SummaryDifference0.0%

- Check66 days agoChange DetectedThe government funding status banner at the top of the page is removed. Standard study details remain unchanged.SummaryDifference0.1%

- Check81 days agoChange DetectedThe two screenshots show the same ClinicalTrials.gov page with no changes to the title, sections, or data. The content and layout appear identical.SummaryDifference0.1%

- Check109 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference1%

Stay in the know with updates to VELIA Clinical Trial: Veliparib in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.